QIAGEN N.V. (QGEN) is a publicly traded Healthcare sector company. As of October 9, 2026, QGEN trades at $45.40 with a market cap of $9.20B and a P/E ratio of 0.00. QGEN moved +1.91% today. Year to date, QGEN is +0.42%; over the trailing twelve months it is -3.30%. Its 52-week range spans $32.53 to $57.82. Analyst consensus is buy with an average price target of $45.12. Rallies surfaces QGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks QGEN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $45.40 |
| Market Cap | $9.20B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 1.26% |
| 52-Week High | $57.82 |
| 52-Week Low | $32.53 |
| Volume | 1.10M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
12 analysts cover QGEN: 0 strong buy, 5 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $45.12.